1. Bolat I., Biteker M. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction. Scand Cardiovasc J. 2020;54(3):174–178. DOI: 10.1080/14017431.2019.1709656.
2. Celikkol A., Güzel E.Ç., Doğan M., Erdal B., Yilmaz A. C-Reactive Protein-to-Albumin Ratio as a Prognostic Inflammatory Marker in COVID-19. J Lab Physicians. 2022;13;14(1):74–83. DOI: 10.1055/s-0041-1741439.
3. Demirkol M.E., Bilgin S., Kahveci G., Kurtkulagi O., Atak Tel B.M., Duman T.T., Aktas G. C-reactive proteinto- lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study. Cir Cir. 2022;90(5):596–601. DOI: 10.24875/CIRU.22000124.
4. Giner-Galvan V., Pomares-Gómez F.J., Quesada J.A., Rubio-Rivas M., Tejada-Montes J., Baltasar-Corral J. On Behalf Of The Semi-Covid-Network. C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19. Biomedicines. 2022;13,10(6):1393. DOI: 10.3390/biomedicines10061393.
5. Fujiwara R., Takemura K., Fujiwara M., Yuasa T., Yasuoka S., Komai Y. Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab. Clin Genitourin Cancer. 2021;19(2):e78–e83. DOI: 10.1016/j. clgc.2020.10.007.
6. Hacker U.T., Hasenclever D., Baber R., Linder N.,Busse H., Obermannova R. Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and do minates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing firstline treatment from the phase III EXPAND trial. Ann Oncol. 2022;33(7):685–692. DOI: 10.1016/j.annonc. 2022.03.274.
7. Hou J., Feng W., Liu W., Hou J., Die X., Sun J. The use of the ratio of C-reactive protein to albumin for the diagnosiof complicated appendicitis in children. Am J Emerg Med. 2022;52:148–154. DOI: 10.1016/j.ajem.2021.12.007.
8. Karimi A., Shobeiri P., Kulasinghe A., Rezaei N. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis. Front Immunol. 2021;22(12):741061. DOI: 10.3389/fimmu.2021.741061.
9. Kaplan M., Ates I., Akpinar M.Y., Yuksel M., Kuzu U.B., Kacar S. Predictive value of C-reactive protein/albumin ratio in acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2017;15-16(4):424–430. DOI: 10.1016/S1499- 3872(17)60007-9.
10. Kunutsor S.K., Laukkanen J.A. Serum C-reactive protein-to-albumin ratio is a potential risk indicator for pneumonia: Findings from a prospective cohort study. Respir Med. 2022;199:106894. DOI: 10.1016/j. rmed.2022.106894.
11. Liao C.K., Yu Y.L., Lin Y.C., Hsu Y.J., Chern Y.J., Chiang J.M., You J.F. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an upda ted systematic review and meta-analysis. World J Surg Oncol. 2021;1,19(1):139. DOI: 10.1186/s12957-021-02253-y.
12. Liu Y., Gao Y., Liang B., Liang Z. The prognostic value of C-reactive protein to albumin ratio in patients with sepsis: a systematic review and meta- analysis. Aging Male. 2023;26(1):2261540. DOI: 10.1080/13685538.2023.2261540.
13. Mariadi I.K., Somayana G., Shalim C.P., Sindhughosa D.A., Daniella D., Purwanta M.L. Prognostic value of C-reactive protein-to-albumin ratio in acute pancreatitis: a systematic review and meta-analysis. F1000Res. 2023;22(12):748. DOI: 10.12688/f1000research. 134938.2.
14. Nishi M., Shimada M., Tokunaga T. Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer. World J Surg Onc. 2021;19:201. DOI.org/10.1186/s12957-021-02319-x.
15. Stefan G., Stancu S., Zugravu A., Capusa C. Inflammation- based modified Glasgow prognostic score and renal outcome in chronic kidney disease patients: is there arelationship? Intern Med J. 2022;52(6):968–974. DOI: 10.1111/imj.15251.
16. Utsumi M., Inagaki M., Kitada K., Tokunaga N., Yunoki K., Sakurai Y. et al. C-reactive Protein-to-Albumin Ratio Predicts Conversion from Laparoscopic to Open Cholecystectomy in Acute Cholecystitis. In Vivo. 2023;37(2):887–893. DOI: 10.21873/invivo.13157.
17. Wang Y., Gong Y., Chen D., Xu F., Yang P. C-Reactive Protein/Albumin Ratio Is Associated with Mortality in Patients with Moderate to Severe Traumatic Brain Injury. World Neurosurg. 2023;173:234–240. DOI: 10.1016/j. wneu.2023.02.037.
18. Wu Y., Sun K., Liu R., Wu L., Zeng Y., Li M., Xu J., Shen B. C-reactive protein/albumin and C-reactive protein/ fibrinogen ratios for the diagnosis of periprosthetic joint infection in revision total joint arthroplasty. Int Immunopharmacol. 2023;115:109682. DOI: 10.1016/j.intimp.2023.109682.
19. Yang C., Ren G., Yang Q. Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis. Front Surg. 2023;9:1094973. DOI: 10.3389/fsurg.2022.1094973.
20. Zavalaga-Zegarra H.J., Palomino-Gutierrez J.J., Ulloque- Badaracco J.R., Mosquera-Rojas M.D., Hernandez- Bustamante E.A., Alarcon-Braga E.A. et al. C-Reactive Protein-to-Albumin Ratio and Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta- Analysis. Trop Med Infect Dis. 2022;16,7(8):186. DOI: 10.3390/tropicalmed7080186.
21. Zehir R., Yılmaz A.S., Çırakoğlu Ö.F., Kahraman F., Duman H. Modified Glasgow Prognostic Score Predicted High- Grade Intracoronary Thrombus in Acute Anterior Myocardial Infarction. Angiology. 2023;17:33197231157929. DOI: 10.1177/00033197231157929.